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Abstract 
Mucinous tubular and spindle cell carcinoma (MTSCC) is a recent entity introduced in the 
World Health Organization 2004 Classification. It is a tumour of low malignant potential. 
MTSCC is a subtype of renal cell carcinoma (RCC), which is characterized by a 
polymorphous histology, wherein the spindled epithelial cell is an inherent carcinomatous 
component. We report the case of a 57-year-old man presenting with loin pain and dragging 
sensation. Imaging revealed a large mass arising from the left kidney. Radical nephrectomy 
was performed, and histopathology revealed spindle cell elements of MTSCC with low-grade 
cytology, which occasionally blended with tubular structures in variable mucinous stroma 
admixed with spindle sarcomatoid cells with marked nuclear pleomorphism, associated 
with significant necrosis and mitoses of up to 5/10 high-power field. A final diagnosis of 
MTSCC along with high-grade areas consistent with sarcomatoid dedifferentiation was 
made. Sarcomatoid dedifferentiation has been well documented in various subtypes of RCC, 
and its presence signifies a worse prognosis in RCC. 
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Introduction 
Mucinous tubular and spindle cell 
carcinoma (MTSCC) is a low-grade renal 
epithelial neoplasm accepted as an 
individual entity in the World Health 
Organization (WHO) 2004 Classification 
(1). MTSCC has a less malignant 
potential than other subtypes of RCC, 
and so it is of prognostic and therapeutic 
importance to distinguish it from the 
others so as to avoid unnecessary 
adjuvant immunotherapy with interferon-
α and interleukin-2 (1, 2). 
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Histologically, the tumour consists of 
anastomosing tubules of cuboidal and 
spindle cells with low-grade nuclei (2, 3). 
Staining with alcian blue reveals lakes of 
mucin. Immunohistochemical studies show 
that MTSCC is positive for the markers of 
epithelial cells and distal nephron and 
negative for proximal nephron, i.e., epithelial 
membrane antigen+ (EMA+), antibody elexa 
(AE1/AE3+), cytokeratin 7+ (CK7+), CK19+, E-
cadherin+, α-methylacyl-CoA racemase+ 
(AMACR+) and cluster designation 10− 
(CD10−) (4). Sarcomatoid dedifferentiation 
(SD) is seen in many renal cell carcinomas 
(RCCs), which is usually associated with a 
poorer outcome. Tumours containing SD 
have a decreased 5-year survival rate from 
79% to 22% in stage-matched patient 
cohorts; tumours containing >50% SD have 
an even worse prognosis (4). The areas of SD 
are markedly different from the spindle cell 
component of the MTSCC portion of the 
tumour, both histologically and 
immunohistochemically, confirming that the 
spindle cell component seen is part of the 
MTSCC and not the SD portion of the tumour 
(5). High-grade cytology, expansile growth, 
extensive necrosis, high mitotic activity, high 
proliferation fraction and loss of expression of 
α-methylacyl-CoA racemase are some helpful 
features in distinguishing spindle cells of the 
sarcomatoid component from that of the 
native tumour. We report a rare case 
presenting with MTSCC with SD, the 
combination of which has a worse prognosis. 
Case summary 
Approval from institutional Ethics Committee 
was obtained. A 57-year-old male patient 
presented with pain and dragging sensation 
in the left loin along with weight loss. 
Computed tomography examination of 
abdomen showed a large cystic mass of size 
17 × 11 × 24.6 cm arising from the middle 
and upper poles of the left kidney. No 
abdominal lymphadenopathy was observed. 
Ultrasound of the scrotum and colonoscopy 
findings were unremarkable. Beta-human 
chorionic gonadotropin (HCG), serum lactate 
dehydrogenase (LDH), carcinoembryonic 
antigen (CEA) and alpha fetoprotein (AFP) 
values were within normal limits. Left radical 
nephrectomy was performed. 
The operated specimen was encapsulated, 
solid and cystic with visible areas of capsular 
breach, of size 21 × 18 × 7 cm, and encased 
the upper pole and the middle region of the 
kidney. Perirenal fat and Gerota’s fascia were 
not involved. Microscopically, the tumour 
consisted of elongated, anastomosing tubules 
separated by lakes of mucin from a prominent 
spindle cell area. The tubules were composed 
of low cuboidal cells with amphophilic to 
eosinophilic cytoplasm with mild 
anisonucleosis. Foci of SD comprising about 
30% of the tumour were seen, with 
pleomorphic low-grade nuclei. No 
lymphovascular invasion was noted (Figures 
1 and 2). Alcian blue stain showed the typical 
blue-coloured mucin in the stroma between 
the tubules and the cords (Figure 3). The 
tumour cells were diffusely positive for 
cytokeratin 7 (Figure 4), EMA and vimentin 
but negative for CD10. Six cycles of adjuvant 
chemotherapy (vincristine, Adriamycin and 
cyclophosphamide [VAC] regimen), comprising 
cisplatin 50 mg/m2, vincristine 1.0 mg/m2, 
Adriamycin 40 mg/m2/day (Dako, Germany), 
cyclophosphamide 1000 mg/m2 and 
actinomycin-D 0.5 mg/m2 followed by 50 
Gy/25 fractions of cobalt-60 teletherapy were 
given. The patient tolerated the therapy well 
without any appreciable adverse effects and 
unremarkable blood chemistry findings. 
Follow-up after 12 months demonstrated that 
the patient was doing well with no evidence of 
recurrence or metastasis. 
Discussion 
MTSCC is a low-grade tumour. It has a 
preponderance in women and has a good 
prognosis (5, 6). The age of presentation is 
quite varied, from 30 to 80 years (5, 6). The 
complaint presented is usually pain in the 
abdomen, as was observed in our patient 
(6–8). Since the recognition of MTSCC as an 
individual entity by the WHO, several 
variants of the tumour have been described, 
such as mucin-poor MTSCC and MTSCC 
with neuroendocrine differentiation (9, 10). 
SD has been recognized in all types of RCC 
since the Heidelberg classification of renal 
cell tumours was published in 1997 (11). The 
sarcomatoid component has fibrosarcoma-
like appearance, which is reported in 14–
65% of cases (12). Three to 24% tumours 
have no pattern of appearance, while 
hemangiopericytoma-like pattern and 
malignant fibrosarcoma-like appearance 
have also been documented (11–13). Unlike 
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Figure 1. Microscopically, the tumour consisted of elongated, anastomosing tubules separated by 
lakes of mucin from a prominent spindle cell area. The tubules were composed of low cuboidal cells 
with an amphophilic to eosinophilic cytoplasm with low-grade nuclei. Foci of sarcomatoid 
differentiation were seen with pleomorphic high-grade nuclei without any evidence of vascular 
invasion. Haematoxylin and eosin, 10×. 
the spindle sarcomatoid cells, the inherent 
spindle cell elements of MTSCC have 
distinctively low-grade cytology, and they 
occasionally blend with tubular structures 
and variable mucinous stroma. 
Immunohistochemistry of MTSCC shows 
that the neoplastic cells of both the 
tubules and the spindle cells are strongly 
positive for PAX 2/8, cytokeratin 7 and 8, 
EMA, AMACR and E-cadherin, with 
variable expression of vimentin and high-
molecular-weight cytokeratin (14, 15). The 
sarcomatoid cells are associated with 
significant necrosis, marked nuclear 
pleomorphism, high mitotic activity, 
higher proliferation fraction (MIB1) and 
loss of AMACR or cytokeratin 7 expression 
(16, 17). 
Figure 2. MTSCC: Foci of sarcomatoid differentiation were seen with pleomorphic high-grade nuclei 
without any evidence of vascular invasion. Haematoxylin and eosin, 40×. 
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Figure 3. The typical blue-coloured mucin in the stroma between the tubules and the cords. Alcian blue 
stain, 40×. 
Ours is an unusual case of MTSCC with SD 
in a 57-year-old man; only a few of such 
cases have been described yet. Features like 
interconnecting tubules of low-grade 
cuboidal cells in a mucinous matrix with 
areas of benign spindle cells were diagnostic 
of MTSCC in our case. A distinct focus of 
high-grade morphology consistent with SD 
was seen. Diagnosis of MTSCC with SD was 
assisted by immunohistological findings, 
which showed strong positivity for AMACR,  
EMA, cytokeratin 7 and vimentin. 
The differentials of MTSCC include 
papillary RCC, collecting duct carcinoma 
and metanephric adenoma. Papillary RCC 
lacks a spindle cell component and rarely 
shows lakes of mucin. Collecting duct 
carcinoma shows high-grade histological 
features and lacks mucin. Metanephric 
adenoma shows tubulopapillary 
architecture, but stromal and spindle cell 
components are lacking (12–15). 
MTSCC with sarcomatoid differentiation has 
a poor prognosis despite the low malignant 
potential of MTSCC, with widespread 
metastasis to lymph nodes, bones and 
lungs in approximately 55.4% of the cases 
(5, 18). Distinction of the sarcomatoid 
Figure 4. MTSCC: Immunohistochemistry showing diffuse positivity for cytokeratin in the tumour cells. 
IHC cytokeratin, 40×. 
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histology from the inherent spindle cell 
component of MTSCC is important because 
of its unfavourable prognostic implication 
(18, 19). Dhillon et al (5) and Bulimbasic et 
al (20) have reported 5 cases of the 
sarcomatoid variant of MTSCCs with 
aggressive behaviour, of which distant 
metastases with fatal outcome were seen in 
3 cases. This may suggest that 
sarcomatoid changes are related to the 
biobehaviour of MTSCCs (20). Therefore, 
the presence of SD is a harbinger of poor 
prognosis and must be reported in any 
type of RCC. The presence of spindle cells 
in MTSCC may be confused with small 
areas of SD, so adequate sampling and 
careful histological examination are 
required in all MTSCC cases (8). It is 
essential that areas of atypical spindle 
cells, especially when associated with 
necrosis, should be reported and the 
possibility of SD considered (8, 15). Thus, 
it is essential to search for areas of 
sarcomatoid differentiation in the case of 
MTSCC so that complete surgical resection 
in the form of radical nephrectomy and 
radiation therapy is employed, followed by 
regular clinical and radiological follow-up 
to exclude possible metastatic disease 
(19, 20). 
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